Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
December 31, 2023 13.41M
September 30, 2023 23.70M
June 30, 2023 35.01M
March 31, 2023 46.13M
December 31, 2022 62.18M
September 30, 2022 80.26M
June 30, 2022 97.34M
Date Value
March 31, 2022 112.66M
December 31, 2021 128.62M
September 30, 2021 93.63M
June 30, 2021 109.23M
March 31, 2021 55.97M
December 31, 2020 -24.90M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Bio-Path Holdings, Inc. -9.687M
Myrexis, Inc. --
Arrowhead Pharmaceuticals, Inc. 465.53M
Athersys, Inc. --
Oncolytics Biotech, Inc. -6.167M